BIOBIJOU Co.,Ltd. (KOSDAQ:489460)

South Korea · Delayed Price · Currency is KRW

10,950

-550 (-4.78%)

At close: Sep 3, 2026

Market Cap	168.20B -25.0%
Revenue (ttm)	28.56B -16.0%
Net Income	6.52B -16.6%
EPS	428.75 -32.2%
Shares Out	15.04M
PE Ratio	26.08
Forward PE	n/a
Dividend	100.00 (0.91%)
Ex-Dividend Date	Dec 29, 2025

Volume	65,597
Open	11,330
Previous Close	11,500
Day's Range	10,690 - 11,480
52-Week Range	5,230 - 18,450
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 12, 2026

About BIOBIJOU

BIOBIJOU Co.,Ltd. engages in the research, development, manufacturing, and sale of skin booster and filler products in South Korea. It offers cosmetic products which includes skin boosters which is used in treatment to improve skin condition using microneedle therapy system; medical devices include hyaluronic acid dermal fillers under the COLENA PREMIUM and CANDORLOV brand name; and pharmaceuticals, such as include botulinum toxin. It also exports its products to Iraq, the Dominican Republic, Turkey, China, Vietnam, Hong Kong, Russia, Malaysia,... [Read more]

Industry Surgical and Medical Instruments and Apparatus

Founded 2018

Country South Korea

Stock Exchange KOSDAQ

Ticker Symbol 489460

Full Company Profile

Financial Performance

In 2025, BIOBIJOU's revenue was 28.49 billion, a decrease of -3.86% compared to the previous year's 29.63 billion. Earnings were 4.15 billion, a decrease of -42.24%.

Financial Statements